SVF
Level D· Preclinical EvidenceLaboratory Study

Human Secretomes, Plant Exosomes, and Hybrid Secretomes Intradermal Injections for Hair Regeneration: Experimental Study.

Adel N., Kolenda J., Thulesen J., Crespo FHG., Shen Y., Jo YK.

Laboratory Study on Hair Regeneration, published in Plast Reconstr Surg Glob Open (2026) — summary generated from the PubMed abstract.

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Plast Reconstr Surg Glob Open (2026)
Country
United States
Reported sample size
—
PMID
42559508
DOI
10.1097/GOX.0000000000007979

Abstract (original English)

Hair follicle regeneration depends on coordinated interactions between different cells and signaling pathways controlling proliferation. Biologically derived injectable formulations, including human secretomes, plant exosomes, and hybrids, are emerging as potential therapeutics, yet their efficacy in intact skin is not understood. The aim of this research was to evaluate and compare the effects of human adipose-derived secretomes, plant-derived exosomes, and a hybrid exosome formulation on hair regeneration in intact skin. A randomized, blinded, controlled study was conducted in healthy hamsters. Each animal received two intradermal injections of human secretomes, plant exosomes, hybrid secretomes, or saline with untreated animals as baseline controls. Skin biopsies were collected at baseline, 73 days, and 93 days. Histology (H&E) assessed follicular morphology, and immunohistochemistry for Ki67, β catenin, and CD34 quantified proliferation, Wnt activation, and stem cell involvement. Ki67-positive cells were highest in hybrid secretomes, followed by plant exosomes and human secretomes, with the lowest levels in controls. Nuclear β catenin localization was most pronounced in human secretome-treated follicles, followed by plant exosomes and hybrid secretomes, whereas controls were largely negative. CD34 expression was highest in hybrid secretomes, followed by human secretomes and

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence comes from animal or laboratory studies and has not been confirmed in humans.

How we grade evidence
Hair & ScalpHair Regeneration
View on PubMedDOI

Related research